Should I order an ultrasound (US) for a 22-week gestation patient with severe anemia, who received 2 units of Packed Red Blood Cells (PRBC), and has fetal heart tones (FHT) heard on Doppler?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ultrasound After Blood Transfusion for Severe Anemia at 22 Weeks

Yes, you should order an ultrasound to assess fetal well-being and evaluate for potential complications related to severe maternal anemia, even though fetal heart tones are audible on Doppler. 1

Rationale for Ultrasound Assessment

Severe Anemia as a High-Risk Condition

  • Severe maternal anemia requiring transfusion at 22 weeks constitutes a high-risk pregnancy that warrants formal fetal surveillance. 1 The American College of Radiology recommends antenatal fetal surveillance for high-risk conditions, and severe anemia requiring blood transfusion clearly falls into this category. 1

  • Maternal anemia can compromise uteroplacental oxygen delivery, potentially affecting fetal oxygenation and growth. 2 This creates a physiologic stress on the fetus that requires assessment beyond simple heart tone detection. 2

Limitations of Doppler Heart Tone Detection Alone

  • Audible fetal heart tones on handheld Doppler confirm cardiac activity but provide no information about fetal well-being, growth, amniotic fluid status, or placental function. 3, 1 Doppler detection of heart tones is reassuring for viability but insufficient for comprehensive fetal assessment in high-risk scenarios. 3

  • Fetal anemia itself can develop secondary to maternal anemia in some cases, and this requires specific ultrasound assessment including middle cerebral artery Doppler velocimetry. 4 Peak systolic velocity in the middle cerebral artery is the current standard for diagnosing fetal anemia. 4

Recommended Ultrasound Components

Essential Elements of the Assessment

  • Perform a comprehensive transabdominal ultrasound including fetal biometry to assess for appropriate growth and to establish a baseline for future surveillance. 5 At 22 weeks, this allows evaluation of fetal anatomy and detection of any growth abnormalities. 5

  • Assess amniotic fluid volume using either maximum vertical pocket (MVP ≥2 cm is normal) or amniotic fluid index (AFI ≥8 cm is normal before 37 weeks). 1 Oligohydramnios may indicate uteroplacental insufficiency related to the severe anemia. 1

  • Evaluate placental location, appearance, and cord insertion sites. 5 This provides baseline information important for ongoing pregnancy management. 5

  • Consider middle cerebral artery Doppler assessment to evaluate for fetal anemia. 4 Peak systolic velocity measurements can detect fetal anemia non-invasively and guide further management. 4

Additional Considerations Based on Findings

  • If growth restriction is identified, umbilical artery Doppler should be performed, as this has demonstrated benefit in reducing perinatal mortality in growth-restricted fetuses. 5 Absent or reversed end-diastolic flow is always abnormal and requires urgent management. 1

  • Document fetal anatomy thoroughly, as this examination at 22 weeks serves as the standard second-trimester anatomic survey. 5 The American College of Radiology recommends at least one ultrasound be offered to all pregnant women between 18-20 weeks. 5

Ongoing Surveillance Strategy

Follow-up Protocol

  • Establish a surveillance schedule based on initial ultrasound findings, typically every 2-4 weeks for growth assessment in high-risk pregnancies. 5 More frequent monitoring may be warranted if abnormalities are detected. 5

  • Serial middle cerebral artery Doppler assessments should be performed if fetal anemia is suspected or if maternal anemia was severe enough to potentially affect fetal oxygen delivery. 4 This allows early detection of developing fetal anemia before clinical decompensation. 4

  • Initiate formal antenatal testing (nonstress tests, biophysical profiles) at 32-34 weeks if not earlier based on findings. 1 The timing should be individualized based on severity of maternal condition and any fetal abnormalities detected. 1

Critical Clinical Caveats

Important Pitfalls to Avoid

  • Do not rely solely on audible heart tones as evidence of fetal well-being in high-risk pregnancies. 3, 1 Heart tones confirm viability but provide no information about fetal compromise, growth, or placental function. 1

  • Do not delay ultrasound assessment waiting to see if maternal condition improves. 3 The severe anemia requiring transfusion has already occurred, and fetal effects may be present even after maternal treatment. 2

  • Recognize that no single antenatal test can predict acute events like placental abruption or cord accidents. 1 Ongoing surveillance is necessary throughout the pregnancy, not just a single assessment. 1

  • Be aware that fetal anemia can present with specific heart rate patterns including sinusoidal patterns and late decelerations. 6 These findings on formal monitoring would not be detected by simple Doppler heart tone checks. 6

Documentation and Communication

  • Document the indication for ultrasound (severe maternal anemia requiring transfusion) and ensure comprehensive assessment is performed, not just a limited viability check. 7 The ultrasound should be diagnostic quality with full documentation. 7

  • Communicate findings and establish clear follow-up plans with the patient, emphasizing the need for ongoing surveillance given the high-risk nature of the pregnancy. 1, 2 Patient education about fetal movement monitoring should also be provided. 1

References

Guideline

Fetal Well-being Assessment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Immediate Ultrasound for Fetal Viability Confirmation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fetal anemia: Diagnosis and management.

Best practice & research. Clinical obstetrics & gynaecology, 2019

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fetal anemia and heart rate patterns.

Journal of perinatal medicine, 1982

Research

The routine obstetric ultrasound examination.

Obstetrics and gynecology clinics of North America, 1998

Related Questions

Why is a gestational ultrasound (ultrasound performed during pregnancy) ordered at 8 months of gestation?
Is an ultrasound and repeat genetic testing reasonable for a viable singleton pregnancy with absent fetal heartbeat on Doppler at 11 weeks and 4 days and an error in Non-Invasive Prenatal Testing (NIPT)?
What is a guide to reading Ultrasound (USG) images?
What is the best online obstetrics (OB) ultrasound course?
What are the recommended guidelines for using diagnostic obstetric imaging, such as ultrasound and MRI (Magnetic Resonance Imaging), during early pregnancy to minimize potential risks and ensure optimal prenatal care?
What is the treatment for a patient with a potential tetanus exposure, particularly if they have not been vaccinated against tetanus in the past 10 years or have a dirty wound?
What is the appropriate treatment for a 14-year-old patient with sharp epigastric pain that initially started in the lower abdomen and was accompanied by nausea, and has now localized to the upper gastric area?
What is the preferred antibiotic, Meropenem (generic) or Piperacillin/Tazobactam (Pip/Taz), for a patient with brittle asthma requiring broad-spectrum antibiotic coverage?
What is the best option for immediate pain relief in a patient with GERD, IBS, HIV, and COPD?
What is the recommended treatment approach for a patient diagnosed with hepatitis D?
What is the oral antibiotic of choice for an adult patient with a respiratory Pseudomonas infection, no significant renal impairment, and no history of recent fluoroquinolone use?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.